• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红细胞衰老过程中补体受体1(CR1)的丧失。受体蛋白水解释放的研究。

Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor.

作者信息

Ripoche J, Sim R B

出版信息

Biochem J. 1986 May 1;235(3):815-21. doi: 10.1042/bj2350815.

DOI:10.1042/bj2350815
PMID:2944510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1146760/
Abstract

Complement receptor type 1 (CR1) is a glycoprotein of Mr about 250 000 present on erythrocytes and other cell types. CR1 acts as a cofactor in the factor I-mediated breakdown of complement fragment C3b to form iC3b. Using an assay of cofactor activity, a wide variation in mean CR1 levels between erythrocytes from individual donors is observed. CR1 levels also decrease on ageing of erythrocytes in vivo, and again the rate of loss is widely variable between individuals. However, variable loss of CR1 during ageing of erythrocytes is likely to make only a minor contribution to the observed variation in mean CR1 levels. CR1 is very sensitive to proteolysis, and random proteolytic removal of CR1 from erythrocytes is likely to be an important factor in loss of CR1 on ageing of red cells in vivo. In vitro, mild trypsin treatment, plasmin or thrombin digestion of erythrocytes results in the loss of the factor I cofactor activity from the cell surface, and appearance of this activity in the supernatant. We conclude that an active fragment of CR1 is released from the cell surface on proteolysis. Subsequent prolonged trypsin treatment destroys most of the activity of this fragment. Proteolytic removal of CR1 from red cells may account not only for loss on ageing of cells, but also for the acquired CR1 deficiencies observed by others in systemic lupus erythematosus.

摘要

补体受体1(CR1)是一种存在于红细胞和其他细胞类型上的糖蛋白,分子量约为250000。CR1作为一种辅助因子,参与因子I介导的补体片段C3b降解形成iC3b的过程。通过辅助因子活性检测发现,不同个体供体红细胞的平均CR1水平存在很大差异。在体内,随着红细胞老化,CR1水平也会下降,而且个体之间的丢失速率差异很大。然而,红细胞老化过程中CR1的可变丢失可能仅对观察到的平均CR1水平差异有较小贡献。CR1对蛋白水解非常敏感,红细胞中CR1的随机蛋白水解去除可能是体内红细胞老化时CR1丢失的一个重要因素。在体外,用温和的胰蛋白酶处理、纤溶酶或凝血酶消化红细胞会导致细胞表面因子I辅助因子活性丧失,并在上清液中出现这种活性。我们得出结论,蛋白水解时CR1的一个活性片段从细胞表面释放。随后长时间的胰蛋白酶处理会破坏该片段的大部分活性。红细胞中CR1的蛋白水解去除不仅可能导致细胞老化时的丢失,还可能解释其他人在系统性红斑狼疮中观察到的获得性CR1缺陷。

相似文献

1
Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor.红细胞衰老过程中补体受体1(CR1)的丧失。受体蛋白水解释放的研究。
Biochem J. 1986 May 1;235(3):815-21. doi: 10.1042/bj2350815.
2
Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).健康个体及系统性红斑狼疮(SLE)患者红细胞上CR1(C3b受体,CD35)的外周分解代谢
Clin Exp Immunol. 1992 Mar;87(3):422-8. doi: 10.1111/j.1365-2249.1992.tb03013.x.
3
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.系统性红斑狼疮及其他涉及自身抗体和/或补体激活的疾病患者中与疾病相关的红细胞补体受体(CR1,C3b受体)缺失。
J Immunol. 1985 Sep;135(3):2005-14.
4
Large-scale isolation of complement receptor type 1 (CR1) from human erythrocytes. Proteolytic fragmentation studies.从人红细胞中大规模分离1型补体受体(CR1)。蛋白水解片段化研究。
Biochem J. 1985 Dec 15;232(3):883-9. doi: 10.1042/bj2320883.
5
Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): vesiculation and/or proteolysis?人类红细胞C3b/C4b受体(CR1,CD35)的分解代谢:形成囊泡和/或蛋白水解?
Immunopharmacology. 1997 Dec;38(1-2):129-40. doi: 10.1016/s0162-3109(97)00066-0.
6
Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS.体内人红细胞上CR1的蛋白水解切割:艾滋病中切割增强的证据。
Eur J Immunol. 1994 Mar;24(3):702-8. doi: 10.1002/eji.1830240332.
7
The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.正常受试者和系统性红斑狼疮患者体内衰老红细胞CR1的丢失率:与结构或数量多态性无关。
Clin Exp Immunol. 1988 Apr;72(1):74-8.
8
Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿症患者受影响红细胞上CR1的正常功能。
J Immunol. 1985 Jan;134(1):512-7.
9
Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).体外人中性粒细胞中红细胞对C3b介导吞噬作用的增强:红细胞补体受体CR1和红细胞对活性氧代谢产物(ROM)清除作用的联合效应
Immunology. 1985 May;55(1):97-103.
10
Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.原发性混合性冷球蛋白血症、系统性红斑狼疮和类风湿关节炎患者红细胞上补体C3b/C4b受体(CR1)数量减少:与疾病活动度、抗心磷脂抗体、补体激活及治疗的关系
J Rheumatol. 1991 Jul;18(7):1021-5.

引用本文的文献

1
Invasion and Erythrocyte Aging.入侵和红细胞衰老。
Cells. 2024 Feb 12;13(4):334. doi: 10.3390/cells13040334.
2
Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.补体受体1基因多态性与心血管风险相关。
Atherosclerosis. 2017 Feb;257:16-21. doi: 10.1016/j.atherosclerosis.2016.12.017. Epub 2016 Dec 20.
3
Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children.肯尼亚儿童的红细胞补体受体 1 水平随 Knops 血型、α(+)地中海贫血和年龄而变化。
Genes Immun. 2016 Apr;17(3):171-8. doi: 10.1038/gene.2016.2. Epub 2016 Feb 4.
4
The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.风湿性疾病患者中存在CD55和/或CD59缺陷的红细胞群体反映了一种免疫介导的骨髓源性现象。
Med Sci Monit. 2014 Jan 27;20:123-39. doi: 10.12659/MSM.889727.
5
Diminished expression of complement regulatory proteins on peripheral blood cells from systemic lupus erythematosus patients.系统性红斑狼疮患者外周血细胞上补体调节蛋白表达降低。
Clin Dev Immunol. 2012;2012:725684. doi: 10.1155/2012/725684. Epub 2012 Jun 12.
6
Early and extensive CD55 loss from red blood cells supports a causal role in malarial anaemia.早期且广泛的红细胞 CD55 丢失支持其在疟疾性贫血中起因果作用。
Malar J. 2011 Dec 29;10:386. doi: 10.1186/1475-2875-10-386.
7
Dual role of erythrocyte complement receptor type 1 in immune complex-mediated macrophage stimulation: implications for the pathogenesis of Plasmodium falciparum malaria.红细胞补体受体 1 型在免疫复合物介导的巨噬细胞刺激中的双重作用:对恶性疟原虫疟疾发病机制的影响。
Clin Exp Immunol. 2011 Nov;166(2):201-7. doi: 10.1111/j.1365-2249.2011.04459.x.
8
Complement Receptor 1: disease associations and therapeutic implications.补体受体1:疾病关联及治疗意义。
Mol Immunol. 2009 Feb;46(5):761-72. doi: 10.1016/j.molimm.2008.09.026. Epub 2008 Nov 11.
9
Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1.红细胞补体受体1(CR1)的结扎诱导其与支架蛋白FAP-1形成复合物并聚集。
Blood. 2008 Oct 15;112(8):3465-73. doi: 10.1182/blood-2008-04-151845. Epub 2008 Aug 6.
10
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.红细胞补体受体1(CD35)的消耗与预防系统性红斑狼疮肾发作有关。
Clin Exp Immunol. 2006 Feb;143(2):274-80. doi: 10.1111/j.1365-2249.2005.02983.x.

本文引用的文献

1
HEREDITARY NATURE OF THE BEHAVIOUR OF ERYTHROCYTES IN THE IMMUNE ADHERENCE HAEMAGGLUTINATION PHENOMENON.红细胞在免疫黏附血凝现象中行为的遗传性
Vox Sang. 1965 Mar-Apr;10:177-87. doi: 10.1111/j.1423-0410.1965.tb04335.x.
2
A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.一种测定血清谷草转氨酶和谷丙转氨酶的比色法。
Am J Clin Pathol. 1957 Jul;28(1):56-63. doi: 10.1093/ajcp/28.1.56.
3
The physiological breakdown of the third component of human complement.人类补体第三成分的生理分解。
Mol Immunol. 1980 Jan;17(1):9-20. doi: 10.1016/0161-5890(80)90119-4.
4
Binding of fluid-phase complement components C3 and C3b to human lymphocytes.液相补体成分C3和C3b与人淋巴细胞的结合。
Biochem J. 1981 Sep 15;198(3):509-18. doi: 10.1042/bj1980509.
5
The covalent-binding reaction of complement component C3.补体成分C3的共价结合反应
Biochem J. 1981 Jan 1;193(1):115-27. doi: 10.1042/bj1930115.
6
Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.用人C3b二聚体对人补体(C3b)受体进行表征。
J Immunol. 1981 Oct;127(4):1348-54.
7
Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.系统性红斑狼疮患者红细胞上C3b受体减少的遗传方式。
N Engl J Med. 1982 Oct 14;307(16):981-6. doi: 10.1056/NEJM198210143071604.
8
Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.用单克隆抗体亲和层析法纯化人C3b灭活剂。
Biochem J. 1982 Apr 1;203(1):293-8. doi: 10.1042/bj2030293.
9
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.系统性红斑狼疮患者红细胞中的补体受体(CR1)缺陷。
J Exp Med. 1982 May 1;155(5):1427-38. doi: 10.1084/jem.155.5.1427.
10
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.鉴定作为人类红细胞、多形核白细胞、B淋巴细胞和单核细胞C3b受体的膜糖蛋白。
J Exp Med. 1980 Jul 1;152(1):20-30. doi: 10.1084/jem.152.1.20.